Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine: an Open Label, Hypothesis Generator Study

NCT04361721 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.

NCT NCT04361721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04361721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine: an Open Label, Hypothesis Generator Study
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2020
Completion date
June 30, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine